ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)

China · Delayed Price · Currency is CNY

38.72

+0.23 (0.60%)

Aug 14, 2026, 3:04 PM CST

-45.25% (1Y)

Market Cap	17.37B -45.3%
Revenue (ttm)	940.78M -21.9%
Net Income	199.99M
EPS	0.44
Shares Out	448.53M
PE Ratio	87.46
Forward PE	33.38
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,643,334
Open	36.55
Previous Close	38.49
Day's Range	36.55 - 39.33
52-Week Range	29.31 - 76.88
Beta	0.77
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About SHE:300723

ApicHope Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China. The company offers pediatric medicines; chronic disease drugs; active pharmaceutical ingredients and formulations; and specialty traditional Chinese medicines. It is also involved in scientific research and technical services; wholesale and retail trade; information technology; and technology promotion and application services. The company was formerly known as ApicHope Pharmaceutical C... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2002

Employees 1,294

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300723

Full Company Profile

Financial Performance

In 2025, SHE:300723's revenue was 932.27 million, a decrease of -35.72% compared to the previous year's 1.45 billion. Losses were -337.79 million, -37.45% less than in 2024.

Financial Statements